AZOM13h
esmo group Launches Apollo Quad Handler to Revolutionize Semiconductor Testing
esmo group (esmo), a leading global full-service systems integrator, developer, and supplier of innovative and advanced automation solutions, is proud to announce the launch of its latest product—the ...
emjreviews.com13d
Therapeutic Advances in Gastrointestinal Cancers: Immuno-oncology and Beyond
This Industry Satellite Symposium was presented at the European Society for Medical Oncology (ESMO) Congress 2024, held in ...
emjreviews.com13d
ESMO 2024 Abstract Highlights
The following abstracts showcase the top cutting-edge research presented at the European Society for Medical Oncology (ESMO) ...
CNN14d
Updated guidelines may help reduce the risk of a first-time stroke, according to the American Stroke Association
The guidelines encourage a series of healthy behaviors to help people avoid some common risk factors for strokes like obesity, high blood pressure and elevated cholesterol. New findings in the ...
Women's Health14d
Mammogram Screening Guidelines Have Never Been More Confusing. Here’s When You Should Get One, According To Doctors
Despite this being a month packed with reminders to schedule your screening, the guidelines on when you should begin making mammograms a part of your annual medical checklist are incredibly unclear.
Daily15d
Novartis' Ribociclib named as Category 1 Preferred Adjuvant Treatment for Breast Cancer in NCCN Guidelines
Basel: This month, the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for breast cancer were updated to ...
Pharmabiz16d
Novartis ribociclib recognized as Category 1 preferred breast cancer adjuvant treatment by NCCN Guidelines
Novartis ribociclib recognized as Category 1 preferred breast cancer adjuvant treatment by NCCN Guidelines: Basel Saturday, October 26, 2024, 14:00 Hrs [IST] This month, the NCCN ...
The Financial Express17d
NCCN Guidelines recognises Novartis’ ribociclib as Category 1 preferred breast cancer adjuvant treatment
(Image Credits: Pexels) The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for breast cancer were updated this month to recommend ribociclib (Kisqali) as a Category 1 preferred ...
Novartis24d
Novartis receives positive CHMP opinion for Kisqali® to help reduce risk of recurrence in people with HR+/HER2- early breast cancer
An updated analysis from the NATALEE trial recently presented at the European Society for Medical Oncology (ESMO) Congress 2024 adds to the growing body of evidence supporting the potential of Kisqali ...
Seeking Alpha26d
Sutro Biopharma: Post ESMO Selloff, Does Their Strategy In FRα Remain Viable?
Seeing the disappointing post ESMO selloff (across a number of companies ... The impact of AbbVie's Elahere is misrepresented in my eyes, as NCCN guidelines recommend its use with Avastin in ...
Channel NewsAsia Singapore27d
Singapore authorities developing guidelines to help employers manage extreme weather risks
A ministry spokesperson told CNA that they will finalise and release the guidelines after consultations with the industry and public. It did not specify a timeline. This comes about three weeks ...
UroToday28d
European Society for Medical Oncology (ESMO) 2024 Annual Congress Coverage Starts Friday
At ESMO 2024, Bayer will present key results from the Phase III ARANOTE trial on NUBEQA® (darolutamide) for metastatic hormone-sensitive prostate cancer and the PEACE-III study of XOFIGO® (radium-223) ...